The Trump administration is “very anxious” to create a pathway for access to psychedelics therapy, U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. says, and top officials across federal agencies want to “get it out to the public as quickly as possible.”
In an interview on the Joe Rogan Experience podcast that was released on Friday, Kennedy said he’s confident “we’re going to get it done,” with plans to develop and finalize rules that would enable patients with conditions such as post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled setting.”
The secretary has stood out for his advocacy for psychedelics reform, pitching the idea as a 2024 Democratic presidential candidate before ultimately becoming the nation’s top health official under the Trump administration.
The president himself has been largely silent on the issue, but as Kennedy noted, support for expanding research and access to the novel therapeutics extends beyond HHS, with the heads of the U.S. Department of Veterans Affairs (VA), Food and Drug Administration (FDA) and National Institutes of Health (NIH) also looking to tap into the potential benefits of psychedelic medicines.
“Everybody
Read full article on Marijuana Moment
